Preparation of Neuroplant® 300mg N in film-coated tablets (St. John´s wort, SJW) in the treatment of mild to moderate Major Depressive Disorder (MDD) in adolescents from 12 to 17 years (inclusive): a parallel group, randomized, double-blind, placebo (PBO)-controlled, multicentre clinical trial to evaluate the efficacy, safety, somatic and behavioral Adverse Events (AEs) and pharmacokinetics of SJW in mild to moderate MDD in adolescents.
Active, not recruitingDRKS00000287
Universitätsklinikum Ulm
Klinik für Kinder- und Jugendpsychiatrie/PsychotherapieF32.0
F32.1
Start: 2010-11-03Target: 238Updated: 2025-04-07